(3H)norepinephrine binding and lipolysis by isolated fat cells.
D000273:Adipose Tissue / Q000378:metabolism*; D000818:Animals; D001665:Binding Sites; D002395:Catecholamines / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004822:Epididymis; D004837:Epinephrine / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D007545:Isoproterenol / Q000494:pharmacology; D007700:Kinetics; D050356:Lipid Metabolism; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000378:metabolism*; D010646:Phentolamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011134:Polysaccharides; D011188:Potassium / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011485:Protein Binding; D051381:Rats; D013997:Time Factors; D014316:Tritium
D002395:Catecholamines; D005230:Fatty Acids, Nonesterified; D011134:Polysaccharides; D014316:Tritium; D010656:Phenylephrine; D004295:Dihydroxyphenylalanine; D011433:Propranolol; D008274:Magnesium; D007545:Isoproterenol; D011188:Potassium; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine